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Adenoviruses with deletion of E1b gene can selectively replicate in cancer cells. The underlying mechanisms in tumor-selective replication of
E1b-deleted adenoviruses are insufficiently understood. Identifying genes with altered expression patterns caused by the E1B proteins in virus-
infected cells will further increase our understanding of E1B functions and provide insight into the tumor-selective replication of E1b-mutated
adenoviruses on the molecular level. An approach based on large-scale gene array was applied to analyze molecular changes affected by viral
E1B. We identified a total of 345 genes with expression changes of two-fold or greater affected by wild-type adenovirus compared with its E1b-
deleted counterpart. The gene array data were confirmed by quantitative real-time PCR and Western blot. E1B proteins affect the expression of a
diverse range of genes involved in cell cycle regulation, apoptosis, stress responses and angiogenesis. This is the first study of the global profile of
gene expression altered by the viral E1B proteins in human lung cells, and the majority of the genes were previously not known to be affected by
the viral proteins. The data presented in this study will lead to more detailed analysis of E1B functions and may also lead to development of new
agents and approaches for oncolytic therapy.
© 2006 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Cell cycle; Gene array; E1B; Viral replicationIntroduction
Adenoviruses (Ad) E1b gene encodes two major poly-
peptides of 55,000 kDa (55K) and 19,000 kDa (19K), both
required for transformation of rodent cells by viral infection
and DNA transfection (Barker and Berk, 1987; Stillman,
1986). The E1B55K protein protects the infected cells from
the E1A-induced p53 effects by two mechanisms: E1B55K
binds to the amino terminus of p53, thus inhibiting p53
transactivation (Debbas and White, 1993; Kao et al., 1990;Abbreviations: Ad, adenovirus; WT, wild type; MOI, multiplicity of
infection; PFU, plaque forming unit(s).
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doi:10.1016/j.virol.2006.02.009Lowe and Ruley, 1993; Martin and Berk, 1998); E1B55K,
together with the Ad E4orf6 protein, degrades p53 protein in
Ad-infected cells (Grand et al., 1994; Querido et al., 2001;
Steegenga et al., 1998). The E1B55K protein also modulates
transport or cytoplasmic stabilization of viral and host cell
mRNA (Pilder et al., 1986). The adenoviral E1B19K protein
is the putative Bcl-2 functional homolog and a strong
apoptotic inhibitor (Debbas and White, 1993; Rao et al.,
1992; White et al., 1992). It is thought that E1B19K
prevents E1A-induced apoptosis by interfering with the
actions of the pro-apoptotic proteins Bak and Bax (Cuconati
et al., 2002). Through the action of these E1b-encoded
proteins, premature cell death is prevented and viral
replication is maximized. In transient expression assays,
the Ad E1B19K increases expression from the promoter for
the cellular 70-kDa heat shock protein (hsp70) (Herrmann
and Mathews, 1989).
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al., 2002), it is thought that E1B19K deletion should lead to
more rapid viral release from apoptotic cells and result in
enhancement of viral spread in tumor tissues. Several publica-
tions have described the antitumoral effects of E1B19K mutants
for the treatment of cancers in vitro and in vivo (Harrison et al.,
2001; Hay et al., 1999; Sauthoff et al., 2000). Tumor-selective
replication of adenovirus mutants, such as dl1520 with an
E1B55K deletion, is one of the promising approaches in cancer
gene therapy. However, clinical trials have shown that the
effects of dl1520 as a single agent in human cancer treatments
are limited (Biederer et al., 2002; Kirn, 2001; Ries and Korn,
2002). Previous research results to explain how the selective
replication occurs are a controversy. One hypothesis was that
dl1520 selectively replicates in and destroys tumor cells
carrying mutations of the p53 tumor suppressor gene because
the E1B55K functions are not required in these cells (Bischoff
et al., 1996; Heise et al., 1997; Rogulski et al., 2000). However,
work by several laboratories found that a variety of tumor cell
lines, regardless of their p53 status, allow efficient replication of
dl1520 and other E1B55K-deleted viruses (Dix et al., 2001;
Geoerger et al., 2002; Hobom and Dobbelstein, 2004; Rao et al.,
2004). Recent reports show that infection with viruses deleted
with E1B55K or expressing mutated E1B55K that specifically
lacks p53 binding ability increased p53 protein level in infected
cells (Hobom and Dobbelstein, 2004; O'Shea et al., 2004).
However, the accumulated p53 protein is transcriptionally
inactive because expression of p53-responsive genes MDM and
p21 was not affected in the cells infected with the E1B55K-
mutated viruses. Therefore, E1B55K role in blocking p53-
induced transcription is not required during adenovirus
infection.
Recently, we showed that a virus deleted for both E1B55K
and E1B19K induced more profound apoptosis in comparison
to wild-type adenovirus (Adwt) and viruses with mutation only
in E1B55K (Rao et al., 2004). However, the virus Adhz60 with
deletion of entire E1B gene (E1B55K and E1B19K) still can
replicate in the majority of the infected cancer cell population
(Rao et al., 2004). Therefore, the study with other recent reports
suggests that the p53 inactivation and apoptosis inhibition by
E1B55K and E1B19K are not critically necessary in virus
replication, implying that the E1B proteins may have other roles
in infected cells.
Determination of the expression profile of genes affected by
viral E1B proteins will increase our molecular knowledge of
E1B functions in virus and host cell interactions. This study
provides the first global analysis of E1B-associated gene
expression changes in human lung WI-38 cells derived from
normal lung tissue. Unlike cancer cells, WI-38 cells require the
E1B proteins for virus efficient replication (Zheng et al., 2005a).
Using gene expression profiling, we identified a total of 345
genes with expression altered by two-fold or greater induced by
Adwt compared to its E1B deletion counterpart. Adenoviral
E1B proteins were found to affect the expression of a diverse
range of genes involved in cell cycle regulation, apoptosis,
stress responses and angiogenesis. Changes in some gene
expression were confirmed by quantitative real-time PCR andWestern blot. This study presents cellular gene expression
profiles of human lung cells affected by adenoviral E1B
proteins, which will provide new clues to further study
adenoviral E1B functions in viral life cycle and the mechanism
of tumor-selective replication of E1B-mutated viruses.
Results and discussion
E1B proteins regulate host cellular gene expression by
controlling RNA levels
Elucidation of viral E1B-associated molecular changes of
human cells will help to better understand the molecular
process related to E1B proteins and possibly provide the basis
for the identification of novel targets for cancer therapy. There
are no reports that have studied the gene expression profile of
E1B in normal cells. Most of the knowledge about E1B
activities comes from the analysis of individual genes in
cancer cell lines using E1B-mutated adenovirus. In our study,
we focused on the changes in cellular gene expression profiles
between infections with Adwt or the E1B-deleted Adhz60 in
order to understand the molecular alterations caused by E1B
proteins.
We infected WI-38 cells with Adwt (E1B+) or Adhz60
(E1B−). Adhz60 is a recently created adenovirus deleted for
the entire E1B gene, so that the only difference between Adwt
and Adhz60 is that lack of both E1B19K and E1B55K in
Adhz60 (Rao et al., 2004). WI-38 is a human diploid cell line
derived from normal embryonic lung tissue. Using a normal
lung cell line instead of a cancer cell line (such as HeLa) will
allow us to better reveal the natural function of viral E1B
proteins. In our study, total RNAs were isolated from WI-38
cells at 12 h post-infection with Adwt or Adhz60 at an MOI of
100 in two separate experiments. As the viral E1B proteins are
the early proteins and their effect on gene expression should be
mostly at the early stage, we are only interested in expression
changes of cellular genes affected at 12 h after infection.
Comparison was performed between Adwt vs. Adhz60 to
account for changes caused by the presence of the viral E1B
proteins. In microarray analysis, 345 genes (1.56% of all the
genes present on the array) with the same expression pattern in
duplicate experiments exhibited over 2-fold (up to 27.7-fold)
alteration of expression when comparing the infection of Adwt
with Adhz60 (Fig. 1). Of these 345 genes, 77 genes were
upregulated and 268 genes were downregulated by E1B
proteins. Five-fold or greater alterations in expression were
exhibited by 23 of the genes (5 genes upregulated and 18
genes downregulated). Most of these genes were found to
encode proteins with known functions and 83 genes with
unknown function. We used the NetAffx Analysis Center
(Affymetrix, Santa Clara, CA) and GeneSpring (Silicon
Genetics, Redwood City, CA) to categorize the genes with
over 2.5-fold change when comparing Adwt with Adhz60
infection, i.e., changes caused by E1B. These genes and their
major functions involved in cell cycle, apoptosis, transcription,
stress and immune responses or protein metabolism are listed
(Table 1). All of the 262 genes with known functions with fold
Fig. 1. Clustergram showing results of cluster analysis of 154 genes selected by
Significant Analysis of Microarrays (SAM) for Adwt/Adhz1520 fold changes
higher than 2.5 during Adwt and Adhz60 infection. A gene tree was created
using the average linkage clustering method. Similarity measure: standard
correlation, only annotated with standard lists, discarded genes with no data in
half the starting conditions. Normalization: values below 0.01 were set to 0.01.
Each measurement was divided by the 50.0th percentile of all measurements in
that sample.
420 X.-M. Rao et al. / Virology 350 (2006) 418–428changes of 2 or higher are listed in Supplemental Table 1. Data
indicate that E1B proteins may play an important role in the
gene regulation of host cells.
Real-time PCR confirms E1B function in host cellular gene
expression
To confirm microarray data, RNA for real-time PCR was
prepared from two separate experiments at 12 h post-
infection of WI-38 cells with Adwt and Adhz60. We chose a
group of genes that were known to be putatively involved in
cell cycle regulation and apoptosis. For most of the genes
tested, the results from microarray and real-time PCR were in
agreement with small standard deviation values (Table 2).
The gene-specific primers used in real-time PCR are also
listed in this table. Data are average from two separate
experiments, each in duplicate, and are reported as the fold
change of gene expression level in Adwt- vs. Adhz60-
infected cells. There were no or very little changes in mock
control vs. AdlacZ control for these tested genes (data not
shown). Also in 99.5% of the fold change values, the
average deviation of the values for the two microarray
experiments, as well as the two real-time PCR experiments,
was less than 2.
The real-time PCR studies confirmed our results obtained
through microarray expression profiling. Both experiments
suggest that E1B proteins may be involved in regulation of gene
expression. Previously, the functions of the E1B proteins during
viral infection have been well known for inhibition of apoptosis
by inactivation of p53 and other apoptotic factors (Shenk,
2001). Our finding suggests that viral E1B proteins may alsocontrol expression of multiple cellular genes involved in cell
cycle regulation, apoptosis, transcription factors, stress and
immune response and protein and RNA metabolism.
E1B proteins increase expression of cyclin E and other
cell-cycle-related genes
The above experiments show that some key regulators of
cell cycle progression, such as CDC25A, cyclin E1, cyclin E2,
PPAT and CDK5R (Table 1), were upregulated during Adwt
infection, whereas there were no significant changes caused
by Adhz60 infection. After infection, adenoviruses can force
quiescent cells into S or S-like phase of the cell cycle to create
an optimal environment for viral replication (DiMaio and
Coen, 2001). We observed here that mRNA of CDC25A, a
key regulator in cell cycle progression, was upregulated 3.18-
fold by the wild-type virus at 12 h, while CDC25A expression
did not change after Adhz60 infection. In addition, expression
of cyclin E1 and cyclin E2 was also upregulated by Adwt.
These genes were less affected by Adhz60 infection. Real-
time PCR confirmed that several of these cell-cycle-related
genes were affected by viral E1B proteins (Table 2). Both
microarray and real-time PCR showed considerably increased
mRNA levels of CDC25A, CCNE1 (cyclin E1) and CCNE2
(cyclin E2), PPAT and CDK5R in WI-38 cells infected with
Adwt, but not with Adhz60 lacking the E1B gene (Tables 1
and 2). Since these genes are involved in regulation of cell
cycle, cell cycle checkpoint or cytokinesis, the results suggest
that viral E1B proteins may be involved in cell cycle
regulation. This cell cycle regulation function of E1B proteins
may be related to Ad E1B55K because previous report
showed that expression of E1B55K leads to the loss of G1
cell-cycle arrest after X-ray irradiation, while cells expressing
the E1B19K still arrest in G1 after DNA damage (Steegenga
et al., 1995).
Heat shock protein 70 and other stress genes are regulated by
E1B
It is well established that adenoviruses have the capacity to
interfere with the host stress and immune responses, mainly
through proteins encoded by the E3 region (Shenk, 2001).
HSPA6, a member of the heat shock protein 70 (Hsp70)
family of molecular chaperones known to act on aberrant
proteins under stress conditions, was upregulated 7.6-fold in
the presence of E1B (Table 1). Undifferentiated HeLa and
embryonic carcinoma cells have the ability to express the
hsp70 gene in the absence of heat induction (Imperiale et al.,
1984). This un-induced hsp70 expression depends greatly on
the particular cell type because the basal expression of the
heat shock gene in WI-38 cells is at least 50 times lower than
in HeLa cells at both the mRNA and protein levels (Imperiale
et al., 1984). It was shown that heat shock response is a
consequence of a specific viral protein function ensuring
proper synthesis of viral proteins and virions (Glotzer et al.,
2000). Ad E1B19K may be involved in increases in
expression from the hsp70 promoter (Herrmann and Mathews,
Table 1
Grouping by functional category of genes whose average expression differed by >2.5-fold (Adwt/Adhz60)
Symbol/
Category
Affymetrix
gene ID
number
Name Specific/Other categories Fold change
Adwt/
Mock
Adzh60/
Mock
Adwt/
Ad60
Cell cycle
CDC25A 204695_at Cell division cycle 25A Cytokinesis, mitosis, protein amino
acid dephosphorylation, regulation
of cyclin-dependent protein kinase activity
3.18 NC 3.41
CCNE1 213523_at Cyclin E1 G1/S transition of mitotic cell cycle,
cytokinesis, regulation of cell cycle
3.36 NC 2.93
CCNE2 205034_at Cyclin E2 Cell cycle checkpoint, cytokinesis
regulation of cell cycle, regulation
of cyclin-dependent protein kinase activity
2.68 NC 2.89
ERF 203643_at Ets2 repressor factor Cell proliferation, regulation of cell cycle,
regulation of transcription from Pol II promoter
−1.87 NC −3.59
PPAT 209434_s_at Phosphoribosyl pyrophosphate
amidotransferase
Glutamine metabolism, metabolism,
nucleoside metabolism, purine base
biosynthesis, purine nucleotide biosynthesis
2.35 NC 2.53
VEGF 211527_x_at Vascular endothelial
growth factor
Angiogenesis, cell migration, cell proliferation,
induction of positive chemotaxis,
negative regulation of apoptosis, neurogenesis,
positive regulation of vascular
endothelial growth factor receptor
signaling pathway, regulation of cell cycle,
response to stress, signal
transduction, vasculogenesis
NC 2.38 −3.10
Apoptosis
DAPK3 203890_s_at Death-associated
protein kinase 3
Induction of apoptosis, protein amino acid
phosphorylation, protein kinase cascade
−5.70 NC −3.03
GULP1 215913_s_at GULP, engulfment adaptor
PTB, domain containing 1
Phagocytosis, engulfment −1.91 NC −3.61
BCL2L1 215037_s_at BCL2-like 1 Anti-apoptosis, apoptotic mitochondrial
changes, negative regulation of survival
gene product activity
−2.77 NC −3.46
RAD21 200607_s_at RAD21 homolog
(S. pombe)
Apoptosis, cell cycle, chromosome
organization and biogenesis
(sensu Eukaryota), chromosome
segregation double-strand break
repair, meiotic recombination, mitosis
−2.95 NC −2.51
Regulation of transcription
ZFP36L2 201369_s_at Zinc finger protein 36,
C3H type-like 2
Cell proliferation 2.25 NC 3.54
EGR1 201693_s_at Early growth response 1 Regulation of transcription, DNA-dependent −2.04 NC −3.91
EZH2 203358_s_at Enhancer of zeste
homolog 2 (Drosophila)
Establishment and/or maintenance of
chromatin architecture, regulation of
transcription, DNA-dependent
1.49 −1.18 2.89
STAT2 205170_at Signal transducer and
activator of transcription 2,
113 kDa
Regulation of transcription from
Pol II promoter, intracellular signaling
cascade, JAK-STAT cascade
−1.91 NC −2.67
TAF13 205966_at TAF13 RNA polymerase II,
TATA box binding protein
(TBP)-associated factor, 18 kDa
Transcription initiation, regulation of
transcription, DNA-dependent
−1.79 NC −2.63
PMX1 205991_s_at Paired related homeobox 1 Regulation of transcription,
DNA-dependent, development
−1.83 1.41 −4.02
ETV1 206501_x_at Ets variant gene 1 Regulation of transcription,
DNA-dependent, transcription
from Pol II promoter
−1.48 NC −3.91
COPEB 208960_s_at Kruppel-like factor 6 Regulation of transcription,
DNA-dependent, cell growth,
B-cell differentiation
−2.69 NC −2.89
HMG20B 209113_s_at High-mobility group 20B Regulation of transcription,
DNA-dependent, cell cycle,
chromatin modification
−1.65 NC −2.76
(continued on next page)
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Table 1 (continued)
Symbol/
Category
Affymetrix
gene ID
number
Name Specific/Other categories Fold change
Adwt/
Mock
Adzh60/
Mock
Adwt/
Ad60
Regulation of transcription
POLR2E 213887_s_at Polymerase (RNA) II
(DNA directed)
polypeptide E, 25 kDa
Transcription, transcription
from Pol II promoter
−2.10 1.41 −4.30
RBM9 213901_x_at RNA binding motif protein 9 RNA metabolism, negative
regulation of transcription,
estrogen receptor signaling pathway
−2.20 1.40 −3.69
ELL2 214446_at Elongation factor,
RNA polymerase II, 2
Regulation of transcription, DNA-dependent,
RNA elongation from Pol II promoter
−3.43 NC −8.79
GEMIN4 205527_s_at Gem (nuclear organelle)
associated protein 4
Nuclear mRNA splicing,
via spliceosome rRNA processing
3.14 NC 3.41
ETV1 217053_x_at Ets variant gene 1 Regulation of transcription,
DNA-dependent, transcription
from Pol II promoter
NC 1.61 −3.15
ENO1 217294_s_at Enolase 1, (alpha) Glycolysis, transcription,
regulation of transcription, DNA-dependent
−2.87 1.54 −9.99
RERE 221643_s_at Arginine-glutamic
acid dipeptide (RE) repeats
Regulation of transcription, DNA-dependent −2.08 NC −4.13
Stress and immune responses (list below + VEGF)
HSPA6 213418_at Heat shock 70 kDa
protein 6 (HSP70B′)
Protein folding, response to
unfolded protein
3.37 NC 7.62
IGLL1 206660_at Immunoglobulin
lambda-like polypeptide 1
Immune response 2.81 NC 3.56
HSPA1A 200800_s_at Heat shock 70 kDa protein 1A
heat shock 70 kDa protein 1B
Protein folding, response to
unfolded protein, mRNA catabolism,
response to unfolded protein
4.47 1.75 2.75
IL6ST 204864_s_at Interleukin 6 signal transducer
(gp130, oncostatin M receptor)
Immune response cell surface receptor
linked signal transduction
NC 1.54 −3.61
CCL18 32128_at Chemokine (C–C motif)
ligand 18 (pulmonary and
activation-regulated)
Chemotaxis, inflammatory response,
signal transduction cell–cell signaling,
response to biotic stimulus antimicrobial
humoral response (sensu Vertebrata)
NC 12.30 −12.38
STIP1 212009_s_at Stress-induced-phosphoprotein 1
(Hsp70/Hsp90-organizing protein)
Response to stress −2.61 3.14 −20.68
Protein metabolism (list below + DAPK3, CDC25A)
SRPR 200917_s_at Signal recognition
particle receptor
(‘docking protein')
SRP-dependent cotranslational
protein-membrane targeting,
intracellular protein transport
−2.62 1.97 −5.39
VAMP3 201337_s_at Vesicle-associated membrane
protein 3 (cellubrevin)
Protein complex assembly, vesicle
docking during exocytosis,
membrane fusion, vesicle-mediated transport
−2.19 NC −2.87
F12 205774_at Coagulation factor XII
(Hageman factor)
Proteolysis and peptidolysis,
blood coagulation, negative regulation
of blood coagulation
1.45 NC 2.85
XPO7 208459_s_at Exportin 7 Protein-nucleus import, docking,
protein-nucleus export, protein transport
NC 1.80 −3.41
PRKCI 209677_at Protein kinase C, iota Protein amino acid phosphorylation,
protein-membrane targeting, cytoskeleton
organization and biogenesis, intracellular
signaling cascade, membrane
organization and biogenesis,
vesicle-mediated transport, establishment
and/or maintenance of epithelial
cell polarity, intercellular junction assembly
and/or maintenance, secretion
−4.63 NC −6.36
Protein metabolism (list below + DAPK3, CDC25A)
TPR 215220_s_at Translocated promoter region
(to activated MET oncogene)
Protein-nucleus import, transport −9.19 NC −18.77
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Table 1 (continued)
Symbol/
Category
Affymetrix
gene ID
number
Name Specific/Other categories Fold change
Adwt/
Mock
Adzh60/
Mock
Adwt/
Ad60
Protein metabolism (list below + DAPK3, CDC25A)
PICALM 215236_s_at Phosphatidylinositol
binding clathrin assembly protein
Protein complex assembly,
receptor mediated endocytosis
−2.66 NC −3.53
SIK2 215752_at SNF1-like kinase 2 Protein amino acid phosphorylation,
protein kinase cascade, regulation of
insulin receptor signaling pathway
4.47 NC 5.86
MMP14 217279_x_at Matrix metalloproteinase
14 (membrane-inserted)
Proteolysis and peptidolysis −3.27 NC −3.36
FKBP8 40850_at FK506 binding protein 8, 38 kDa Protein folding, intracellular signaling cascade NC −6.68 5.03
RNA expression profiles were obtained from WI-38 cells at 12 h after infection with Adwt, Adhz60 or AdlacZ. NC: no significant change.
423X.-M. Rao et al. / Virology 350 (2006) 418–4281989). As Adwt, but not Adhz60, could increase expression of
the heat shock protein in WI-38 cells, E1B proteins may be
involved in this response. As many cancer cells may have
higher levels of hsp70, the function of E1B for inducing the
heat shock response may become not essential for the mutated
adenovirus replication. Thus, this result supports the idea thatTable 2
Validation of microarray data by real-time PCR
Gene
symbol
RT-PCR primers
Cell cycle
CDC25A F: GCGCATTGAGACAGATTCCAA
R: TAATCTGAAGGCCATCCCACC
CCNE1 F: AAGTACACCAGCCACCTCCAGA
R: CCCTCCACAGCTTCAAGCTTT
CCNE2 F: TTGGCTATGCTGGA GGAAGTAA
R: AGTGCTCTTCGGTGGTGTCAT
PPAT F: GAAGGAAGCACCCACAGCATA
R: CTGGAATAAGACGACCAATGCA
CDK5R F: CATGCAAACCAGGAGCATTT
R: TCAACCCTCCAGGTTTACAAGA
RAN F: CCAGTTTCTAACCAGCCTGTGA
R: CACCACTTGCAATCTCCACAAG
SKP2 F: GCACAGGAAATGATGATGCTTC
R: TGGCTGGACTTGAGTTTGGAA
RAD21 F: GGAGGCCAGCAGAACAAACAT
R: TCTACCTGCTGAGGAGGCATCA
CDC25C F: GGTTTCAGCAGAGCTGAAAGCT
R: GCCAGAGTTCCCTGAACCAATA
Apoptosis and others
DAPK3 F: ATATCCTCCTGAGCGGTGCAT
R: TGCTGAAGTACTCCTCGTCGAA
HSPA1A F: TTCAACATGAAGAGCGCCG
R: AGCCACGAGATGACCTCTTGAC
HSPA6 F: AGGCGCAAAATGCAAGACAA
R: TCCAGCTCCCTCTTCTGATGCT
Internal control
β-actin F: CGATCCACACGGAGTACTTG
R: GGATGCAGAAGGAGATCACTG
RNA levels in Adhz60-infected WI-38 cells were compared with Adwt-infected WIheat shock response could significantly improve the cancer
therapy of E1B-mutated viruses (O'Shea et al., 2005).
In addition, our data also showed that STIP1 (stress-induced
phosphoprotein 1) was downregulated 20-fold in cells infected
with Adwt and CCL18 involved in immune response was
increased 12.3-fold in the absence of E1B (Adhz60/mock)Affymetrix ID Adwt/Adhz60 (fold change)
RT-PCR Microarray
204695_at 3.19 3.41
213523_AT 4.82 2.93
205034_AT 2.89 2.89
209434_S_AT 2.20 2.53
204995_AT 2.52 2.4
200749_at 4.23 2.0
203625_x_at 2.63 2.0
200607_s_at −1.21 −2.51
205167_s_at −1.52 −2.0
203890_s_at −1.68 −3.03
200800_S_AT 3.34 2.75
213418_AT 22.25 7.62
NM_001101 NC NC
-38 cells at 12 h post-infection.
Fig. 2. Western blot analysis of cell-cycle-related proteins. WI-38 cells were
infected with mock, Adwt or Adhz60 (MOI = 10). Lysates were assayed by
Western blotting for production of CDC25A, Cyclin E, A, B and actin as
indicated. High levels of cyclin E and CDC25Awere detected in cells infected
with Adwt. Infection with Adwt or Adhz60 did not cause significant change of
cyclin A and D. Actin was used as a control to demonstrate equal loading and
transfer.
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needs further studies.
VEGF expression repressed by E1B
Vascular endothelial growth factor (VEGF) was upregulated
more than 2.38-fold in WI-38 cells after infection with Adhz60
(Table 1), suggesting that VEGF expression is induced by
infection of the E1B-deleted virus. The VEGF induction was
not observed in the Adwt-infected cells. These data indicate that
the viral E1B proteins, encoded in Adwt, can efficiently repress
the VEGF expression. VEGF is a key regulator of angiogenesis,
the process of new blood vessel formation. Normal adult
vasculature is generally quiescent in nature, with endothelial
cells dividing approximately every 10 years. In contrast,
angiogenesis is a crucial process for tumor growth and
metastatic dissemination as it sustains malignant cells with
nutrients and oxygen (Hicklin and Ellis, 2005; Rosen, 2005).
These data suggest that E1B may be an attractive inhibitor for
blocking angiogenesis, important in cancer therapy.
Other genes regulated by E1B
We found that a large number of cellular genes have been
identified as potential targets for regulation by viral E1B
proteins. In addition to cell cycle regulation and stress
responses, genes involved in apoptosis, regulation of transcrip-
tion and protein and RNA metabolism were also affected by
viral E1B proteins. A group of genes involved in transcription
was downregulated in the present of natural E1B (Table 1,
Adwt/Adhz60). These genes include EGR1 (decreased 3.9-
fold), TAF13 (decreased 2.6-fold), COPEB (decreased 2.9-
fold), HMG20B (decreased 2.8-fold) and RERE (decreased 4.1-
fold). Among the genes involved in transcription by Pol II, we
identified STAT2 (decreased 2.7-fold), ETV1 (decreased 3.6-
fold), POLR2E (decreased 4.3-fold) and ELL2 (decreased 8.8-
fold). We also observed that the ZFP36L2 gene, involved in cell
proliferation, was increased about 3.5-fold after infection with
Adwt, and there were no significant changes with Adhz60
(Table 1). Since transcriptional repression by E1A in cancer
cells has been demonstrated for a variety of genes induced by
transcription factors such as STAT2 and TAF13 (Look et al.,
1998; Zhao et al., 2003), E1B55K and/or E1B19K may be
probably involved in the repression in normal cells.
In our previous study, we showed that infection with viruses
deleted for both E1B19K and E1B55K resulted in apoptosis
with cellular DNA degradation (Rao et al., 2004). However,
cells infected with viruses deleted for only E1B55K (same as
dl1520) did not generate fragmented DNA, suggesting that
E1B19K alone can efficiently inhibit E1A-induced apoptosis.
E1B19K is a Bcl-2 homologous oncogene that can block p53-
dependent and -independent apoptosis (Debbas and White,
1993; Rao et al., 1992). We found that BCL2L1 (Bcl-2-like), a
protein that plays an important role in programmed cell death
(Amills and Bouzat, 2003), was downregulated 3.46-fold in
cells infected with Adwt compared with the Adhz60 infection
(Table 1), implying that E1B proteins may also inhibit apoptosisalso through repressing the expression of apoptosis-related
genes.
Confirm E1B-affected gene expression with Western blot
To determine the reliability of the gene expression profile
obtained with cDNA microarray and RT-PCR, we also
determined that the protein levels of CDC25A, cyclins E, A
and D in WI-38 cells affect viral infection. All of the 4 genes are
involved in cell cycle regulation. We already know that mRNAs
of CDC25A and cyclin E are increased 3-fold in WI-38 cells by
viral E1B after infection with Adwt, while expressions of cyclin
A and D are not affected by E1B (Table 1). At 24, 48 and 72 h
after infection with mock, Adwt or Adhz60, total proteins were
isolated for Western blot. Infection with Adwt led to significant
accumulations of CDC25A at 48 and 72 h and cyclin E at 24, 48
and 72 h in comparison with mock and Adhz60 infection (Fig.
2). Infection with Adhz60 also increased cyclin E protein,
especially at 72 h, but the level was still lower than that caused
by Adwt infection. The expression of cyclin A and D was
altered by neither Adwt nor Adhz60. Thus, viral E1B proteins
also led to the accumulation of CDC25A and cyclin E proteins,
but not cyclin A and cyclin D, in a broad range of time (24 to
72 h) after infection (Fig. 2), consistent with the results of
mRNA levels determined by microarray and RT-PCR studies
(Tables 1 and 2). In the late infectious stage, cellular protein
levels may be different from the early stage.
The induction of cyclin E expression by the viral E1B
proteins is especially interesting. Recent studies unfold that
cyclin E plays an important role in oncogenic transformation;
many human tumors, including breast and lung cancers, highly
express cyclin E (Malumbres and Barbacid, 2001; Moroy and
Geisen, 2004). In agreement with earlier reports (Spitkovsky et
al., 1996), CDC25A was upregulated by the wild-type virus at
mRNA and protein levels. Cdc25A expression is required for S-
phase entry and is induced in G1 (Nilsson and Hoffmann,
2000). CDC25A is a candidate oncogene; overexpression of
Cdc25A gene is sufficient for transformation of Rb−/−
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(Galaktionov et al., 1995). Coexpression of CDC25A and
cyclin E is sufficient to induce entry into S phase in quiescent
fibroblasts (Vigo et al., 1999). Our study demonstrated that viral
E1B increased expression of both CDC25A and cyclin E. Thus,
E1B proteins apparently have a novel function involved in the
control of the key cell cycle regulators. This E1B function is
required for adenovirus replication in normal cells but is no
longer required in many cancer cells, probably because
CDC25A and cyclin E expression is already deregulated in
these neoplastic cells.
It is known that Ad-induced cell-cycle deregulation is mainly
achieved by the interaction between E1A and Rb (Cobrinik,
1996; Shenk, 2001). Adenoviral E1A proteins can free E2F
from the Rb/E2F complex by binding to the unphosphorylated
Rb. The E2F proteins induce expression of cyclin E and other
genes that are essential for cell growth activities in S phase by
binding to and activating their promoters (Botz et al., 1996; Dou
et al., 1992; Henglein et al., 1994; Ohtani et al., 1995; Oswald et
al., 1996; Pearson et al., 1991). We observed that Adhz60 did
increase cyclin E expression in the lack of E1B, especially at
late infection stage. However, Adwt (with E1A and E1B) can
further increase cyclin E expression to a higher level (Fig. 2).
We reason that E1B proteins may cooperate with E1A to
increase expression of cyclin E and other cell-cycle-related
genes. With several cancer cell lines, we also observed the E1B
function in induction of cell cycling gene expression that may
be related to tumor-selective replication of E1B55K-mutated
viruses (unpublished data).
We do not know how E1B affect expression of cyclin E,
cdc25A and many other genes. There is the possibility that the
gene expression changes were secondary effects of E1B
deletion, such as decreased RNA stability or increased E1A
proteins in virus-infected cells. The E1B55K protein modulates
transport or cytoplasmic stabilization of viral and host cell
mRNA; infection with an E1B55K mutant (dl338) resulted in
transport and accumulation of cellular mRNAs (Pilder et al.,
1986). There was a report showing the E1B55K ability to inhibit
p53-mediated transcription (Yew and Berk, 1992). Our recent
study has shown that E1B55K can increase viral E1A protein
levels (Zheng et al., 2005b). To determine the E1A levels in this
experimental context, we collected cellular protein from WI-38
cells at 12 h after infection with Adwt or Adhz60 at an MOI of
100 for Western blot. We observed that the high MOIs (100) ofFig. 3. Western analysis of E1A proteins produced in WI-38 cells at 12 h time
point after infection with Mock, Adwt or Adhz60 at an MOI of 100. α-Actin was
used as a control to demonstrate an equal loading and transfer.Adwt and Adhz60 resulted in E1A overexpression in WI-38
cells and there was no significant difference in E1A levels (Fig.
3). Though the use of diploid or near-primary WI-38 cells is a
sensible approach for gene expression studies, recent studies
have shown that the primary cell has a profound effect on the
outcome of viral infection and the pattern of host gene
expression (Gonzalez et al., 2006; O'Shea et al., 2004).
In summary, our data introduce several possible functions of
Ad E1B proteins, some of them not previously recognized. E1B
proteins affect the expression of a diverse range of genes,
including cdc25A and cyclin E involved in cell cycle regulation,
BCL-2 in apoptosis, heat shock 70K protein in stress responses
and vascular endothelial growth factor in angiogenesis. Further
studies and verification of these findings will increase our
understanding of E1B roles in viral replication. These functions
may explain mechanisms of the conditional replication of E1B-
attenuated adenoviruses in cancer cells and help to identify
novel molecular targets for cancer virotherapy. It is expected
that this study will prompt further functional characterization of
viral E1B and its induced cellular genes in the context of virus
and cell interaction.
Materials and methods
Cells culture and adenovirus
The human diploid cell line (WI-38) derived from normal
embryonic lung tissue (Hayflick et al., 1962) was purchased
from ATCC (Rockville, MD ATCC: CCL-75). Cells were
routinely propagated as a monolayer culture in α-MEM,
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) and penicillin (100 U/ml)/streptomycin (100 μg/ml)
solution. Cell culture reagents were obtained from Invitrogen/
Life Technologies (Carlsbad, CA). Cells were cultured in a 5%
CO2 incubator at 37 °C and subcultured every 3–4 days at
approximately 80% confluence.
The wild-type adenovirus (Adwt) is from ATCC (VR-5);
Adhz60 is a recombinant adenovirus with wt E1A and deletions
of both E1B19K and E1B55K (Rao et al., 2004); AdlacZ
(AdβgalΔE1) is a lacZ expressing vector deleted for both E1a
and E1b (Zhou et al., 1996).
Microarray analysis, cRNA synthesis and labeling
WI-38 cells, 2 × 106 cells in 150 mm dishes, were infected
with Adwt or Adhz60 at a multiplicity of infection (MOI) of 100.
At 12 h after infection, total RNA was isolated with TRIzol
reagent (Gibco Life Technologies). We chose this time point to
determine the early effects of viral E1B. First and second strand
cDNA were synthesized from 1 to 2 μg of mRNA using the
SuperScript cDNA Synthesis Kit (Gibco Life Technologies) and
oligo-T7(dT)24 (5-GGC CAG TGA ATT GTA ATA CGA CTC
ACT ATA GGG AGG CGG-3′) primer according to the
manufacturer's instructions. The double-stranded cDNA was
cleaned up using the GeneChip Sample Cleanup Module
(Affymetrix, Santa Clara, CA). cRNAwas synthesized, labeled
with biotinylated UTP and CTP by in vitro transcription using
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and the T7 RNA Transcript Labeling Kit (ENZO Diagnostics).
The cDNAwas incubated with 4 μl of 10× each reaction buffer,
biotin-labeled ribonucleotides, DTT, RNAse inhibitor mix and
2 μl 20× T7 RNA polymerase for 5 h at 37 °C. The labeled
cRNAwas separated from unincorporated ribonucleotides using
the GeneChip Sample Cleanup Module (Affymetrix, Santa
Clara, CA).
Microarray analysis, oligonucleotide array hybridization and
analysis
The cRNA (20.0 μg) was fragmented by heat and ion-
mediated hydrolysis at 90 °C for 35min in 200mMTris–acetate,
pH 8.1, 500 mM KOAc, 150 mM MgOAc. The fragmented
cRNAwas hybridized for 16 h at 45 °C to Human Genome U133
A oligonucleotide arrays (Affymetrix, Santa Clara, CA) contain-
ing 22,000 probe sets. Arrays were washed according to
Affymetrix fluidics protocol EukGE-WS4v2. The arrays were
then stained with phycoerythrein-conjugated streptavidin (Mo-
lecular Probes). The fluorescent signal was amplified using
biotinylated goat anti-streptavidin antibody (Vector Laborato-
ries) and a second staining with phycoerythrein-conjugated
streptavidin. The fluorescence intensities were determined using
a laser confocal GeneArray Scanner 2500A (Agilent). Sample
loading and variations in staining were standardized by global
scaling of the average of the fluorescence intensities of all genes
on an array to a constant target intensity for all arrays. The
scanned images were analyzed, and the signal intensity for each
gene was calculated with the Affymetrix MAS 5.0 algorithm.
Several criteria were used to identify genes whose expression
was affected by Adwt and Adhz60 infection. First, the fold
change of each gene had to be more than two-fold up- or
downregulation. Second, the Change Call had to be marginally
increased (MI) or increased (I) for upregulated genes, and,
marginally decreased (MD) or decreased (D) for downregulated
genes (change P value < 0.006). In addition, only genes whose
signals were both present (detection P value < 0.05) or one
present–one absent in AdlacZ were considered as adenovirus-
responsive genes.
Two completely independent experiments were performed.
Only genes that had changed in same direction in both
experiments with the change P value of <0.006 were considered
for further analysis. These filtering criteria were used to reduce
the false-positive responses and to ensure that only genes whose
expression was reproducibly altered were considered the result
of Adenovirus infection. The final fold changes were calculated
based on the average signal log ratio of the two experiments. We
used the on-line data mining tools from two different software
programs: NetAffx Analysis Center (Affymetrix, Santa Clara,
CA) and GeneSpring (Version 5.0, Silicon Genetics, Redwood
City, CA) to analyze gene expression changes.
Real-time PCR
At 12 h post-infection, RNA was prepared using RNeasy
mini kit along with RNase Free DNase set to remove anytraces of DNA contamination (both kits from QIAGEN,
Valencia, CA). cDNA was prepared from 500 ng of RNA
(TaqMan Reverse Transcription Reagents, ABI/Roche,
Branch burg, NJ) based on manufacturer's instruction. The
template cDNAs (12.5 ng/sample) for mock, Adwt- and
Adhz60-infected cells were mixed with Syber Green master
mix (ABI). Mixtures were aliquoted into 96-well optical
reaction plate along with forward and reverse primers for
each target gene; samples were run in duplicates on an ABI
Prism 7000 sequence detection system. Primers were
designed using ABI primer express software, and amplicon
sizes were all below 200 bp. Data were analyzed using the
comparative CT method, by which the fold change of target
gene samples (Adwt- and Adhz60-infected) normalized to
the housekeeping gene (β-actin) relative to the calibrator
(AdlacZ- or mock-infected) is calculated by the 2 − ΔΔCT
equation, where ΔΔCT = ΔCT (sample) − ΔCT (calibrator)
and ΔCT is the CT value of the target gene subtracted from
the CT value of the housekeeping gene, all determined in
the exponential phase of the reactions (Livak and Schmitt-
gen, 2001). PCR primers are listed in Table 2.
Western blot analysis
Western blot analysis was carried out as described
previously (Rao et al., 2004). WI-38 cells were infected
with various viruses at a multiplicity of infection (MOI) of
10. Cells were harvested at 24, 48 and 72 h post-infection
for cellular protein isolation. Equal amounts (30 μg) of
cellular protein were electrophoresed in SDS-polyacrylamide
gels and transferred to a Hybond-PVDP membrane (Amer-
sham, Arlington Heights, IL). The membrane was incubated
with the antibodies of the mouse anti-cdc25A (F-6), rabbit
anti-cyclin E, mouse anti-cyclin A and anti-cyclin D (Santa
Cruz Biotechnology, Inc. Santa Cruz, CA, USA), diluted
1:200–2000 in phosphate-buffered saline (PBS) containing
0.5% BSA and 0.1% Tween-20. For analysis of viral E1A
proteins in WI-38 cells, the cells were infected with Adwt or
Adhz60 at an MOI of 100 and harvested at 12 h after
infection. Purified mouse anti-adenovirus type 5 E1A
monoclonal antibody (BD Biosiences, San Diego, CA) was
diluted 1:500. Binding of the primary antibody was detected
using anti-mouse or anti-rabbit immunoglobulin (Ig) conju-
gated to horseradish peroxidase (Amersham, Arlington
Heights, IL). ECL reagents were used to detect the signals
according to the manufacturer's instructions (Amersham,
Arlington Heights, IL).
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